首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
【24h】

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy

机译:肥厚型心肌病患者高敏感肌钙蛋白水平升高可检测出无痛且无痛的心肌缺血

获取原文
           

摘要

Introduction High-sensitivity troponin I?(hs-TnI), an extra-precise biomarker for the detection of even small myocardial injury caused by ischemia, has been successfully used in patients with hypertrophic cardiomyopathy (HCM) [1, 2]. In the most recent studies [3, 4], measurements of hs-TnI levels were synchronized with a?noninvasive assessment of hemodynamic parameters in the following way: first, resting echocardiography (including a?provocative maneuver to induce a?left ventricular outflow tract (LVOT) gradient) was performed, followed by ambulatory electrocardiography (ECG) Holter monitoring with devices which allow potential episodes of angina pectoris to be marked by the patients. After the 24-hour ECG Holter monitoring in conditions of typical everyday physical activity, the measurement of hs-TnI level was immediately performed. Interestingly, the biomarker level had a?close time relationship with findings on Holter monitoring [3] and echocardiography [4]. High-sensitivity troponin I?levels were associated with both an increased heart rate during Holter monitoring [3] and a?provoked LVOT gradient [4] (stimuli provoking myocardial ischemia). These findings are corroborated by previous studies in invasive and nonphysiological, atrial pacing stressors [5–7]. From the technical point of view, in patients with HCM, verification of angina pectoris by resting or exercise ECG is practically impossible because of common abnormalities visible on resting ECG (with ischemic-like changes or significant deformation of the QT complex). Aim Nowadays, hs-Tn level measurement seems to be ideal for precise verification of myocardial injury due to the occurrence of ischemia in patients with HCM. The aim of this study was to collect information about episodes of angina pectoris occurring in the 24-hour period preceding the hs-TnI level measurement, both in outpatients from a?clinic and patients hospitalized due to cardiac signs and symptoms. Material and methods A?group of 100 consecutive patients with HCM, both from ambulatory care and admitted to the clinic due to cardiac signs and symptoms (pooled group), were recruited to the study. Patients from our previous ambulatory studies were included in the current study; however, the present investigation is different from the previous one [3, 4] and is based on the history of angina pectoris within 24 h before the hs-TnI measurement. We attempted to investigate...
机译:简介高灵敏度肌钙蛋白I?(hs-TnI)是一种用于检测甚至由缺血引起的微小心肌损伤的超精密生物标志物,已成功用于肥厚型心肌病(HCM)患者[1,2]。在最近的研究中[3,4],通过以下方式将hs-TnI水平的测量与血流动力学参数的无创评估同步:首先,静息超声心动图(包括诱发左心室流出道的调动动作) (LVOT)梯度),然后进行动态心电图(ECG)动态心电图监测,该设备可让患者标记出心绞痛的潜在发作。在典型的日常体育活动条件下进行24小时心电图动态心电图监测后,立即进行hs-TnI水平的测量。有趣的是,生物标志物水平与动态心电图监测[3]和超声心动图[4]的发现具有密切的时间关系。高敏感性肌钙蛋白I水平与动态心电图监测期间心率增加[3]和诱发的LVOT梯度[4](刺激心肌缺血)有关。这些发现已被先前关于侵入性和非生理性心房起搏应激源的研究所证实[5-7]。从技术角度看,在HCM患者中,由于静息心电图上可见的常见异常现象(伴有缺血样变化或QT复合体明显变形),通过静息或运动心电图检查心绞痛实际上是不可能的。目的如今,hs-Tn水平测量似乎是精确验证HCM患者由于缺血而引起的心肌损伤的理想方法。这项研究的目的是收集关于在hs-TnI水平测量之前的24小时内发生的心绞痛发作的信息,包括门诊患者和因心脏体征和症状住院的患者。材料和方法招募了100名连续性HCM患者,他们来自门诊和因心脏征象和症状而入院(合并组)。我们以前的门诊研究中的患者包括在本研究中;然而,本研究与以前的研究[3,4]不同,并且基于hs-TnI测量前24小时内的心绞痛史。我们试图调查...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号